Real-time enrollment status for this malignant neoplasm clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 3:17 PM UTC
| NCT Number | NCT07252739 |
| Recruiting Status | Recruiting |
| Condition | Malignant Neoplasm |
| Phase | PHASE2 |
| Target Enrollment | 140 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | September 1, 2026 (15 hours ago) |
As of September 1, 2026: Clinical trial NCT07252739 is currently recruiting participants. This phase2 study for malignant neoplasm is actively seeking new participants at 3 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07252739 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07252739 was last updated 15 hours ago (September 1, 2026). HelloStudys verifies this status automatically.